Sign in
4

Changes in Ownership

ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000047

CEO bought 119,000 shares at an average $0.01 ($1,226)

From the SEC's structured data for this filing

Trades in this filing

Collier Alan Brian · CEO

Table I: Non-derivative

16 lines
Date Transaction Shares Price Value Owned after D/I
2019-08-23 Purchase : show line 1 in the form +10,000 $0.01 $102 25,075,297 D
2019-08-23 Purchase : show line 2 in the form +2,000 $0.01 $21 25,077,297 D
2019-08-26 Purchase : show line 3 in the form +5,000 $0.01 $52 25,082,297 D
2019-08-26 Purchase : show line 4 in the form +5,000 $0.01 $52 25,087,297 D
2019-08-26 Purchase : show line 5 in the form +10,000 $0.01 $104 25,097,297 D
2019-08-26 Purchase : show line 6 in the form +2,000 $0.01 $20 25,099,297 D
2019-08-27 Purchase : show line 7 in the form +15,000 $0.01 $155 25,114,297 D
2019-08-27 Purchase : show line 8 in the form +10,000 $0.01 $104 25,124,297 D
Open-market purchases · 119,000 sh · avg $0.01 · $1,226
Loading xslF345X03/primary_doc.xml…